RE: £50m profit on £3-5m outlay !! (part 1)26 Aug 2025 09:12
Part 2: Fundraising was arranged by:
• MavDB – one page website https://mavdbconsulting.com/ … could well be a one man organisation as only one person listed on their site or on linkedin
• Founded & Run by – Josh Bartch based in Puerto Rico https://www.linkedin.com/in/josh-bartch-a5361b96/
• According to AI: Josh Bartch is an investor and entrepreneur who has founded several companies, including Evolutionary Ventures LLC, Blackstone Mercantile Group Ltd SAC, and MavDB Consulting LLC. He has extensive experience in financing, structuring, and M&As in global capital markets, with over a billion dollars in transactional value. He co-founded and successfully exited AudioTranscriptionist.com and the dispensary, Doctors Orders. He also co-founded Cannabase.io, a significant cannabis wholesale platform.
In other words: Josh Bartch has had an apparently successful entrepreneurial career and looks to be wealthy enough to be 1 or more of the five investors (especially as MavDB got £2m back)
Under Additional Key Terms of the fundraise (31/1/25):
• No Investor is permitted to exercise notes to the extent that, as a result of such exercise, the Investor will own or control more than 2.99% of the issued ordinary shares of the Company.
• Condition precedent for the fundraise: The entry into a 24-month consulting agreement, in agreed form, by the Company and MavDB for business development and support services totalling £2 million, which is being deducted from the proceeds of the CLN and the Equity Fundraise
Hence, as virtually all warrants now exercised – most shares are now held by new investors not warrant holders:
• The 2.99% cap would also explain why there have not been any RNS announcing warrant holders crossing shareholding thresholds
• Maximum the warrant holders can hold in aggregate is 14.95%
• After the consolidation and then warrant exercise, the existing shareholders from Jan 2025 (36m) can only have 4.2% if they all still hold their shares
• Hence there is >80% in new investors hands (albeit a few % of that is held by companies in lieu of stakes MET1 bought in them)